biomarkers_betaamyloid_plaques

This program offers an engaging and interactive approach to diagnosing and managing Mild Cognitive Impairments, focusing on Alzheimer’s Disease. It aligns with key learning objectives, providing healthcare professionals with the knowledge and tools to address diagnostic challenges, implement early interventions, and develop patient-centered care plans. Participants will learn practical strategies to enhance diagnostic accuracy, create personalized treatments, and communicate effectively with patients and caregivers. This course helps clinicians to provide timely, evidence-based care, ensuring improved outcomes for individuals with neurocognitive impairments, including Alzheimer’s Disease.